1.Davioud-Charvet E, Delarue S, Biot C, Schwöbel B, Boehme CC, Müssigbrodt A, Maes L, Sergheraert C, Grellier P, Schirmer RH, Becker K.. (2001) A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline., 44 (24):[PMID:11708927][10.1021/jm010268g]
2.Salmon-Chemin L, Buisine E, Yardley V, Kohler S, Debreu MA, Landry V, Sergheraert C, Croft SL, Krauth-Siegel RL, Davioud-Charvet E.. (2001) 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity., 44 (4):[PMID:11170645][10.1021/jm001079l]
3.Biot C, Bauer H, Schirmer RH, Davioud-Charvet E.. (2004) 5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials., 47 (24):[PMID:15537352][10.1021/jm0497545]
4.Woolley KL, Nadikudi M, Koupaei MN, Corban M, McCartney P, Bissember AC, Lewis TW, Gueven N, Smith JA.. (2019) Amide linked redox-active naphthoquinones for the treatment of mitochondrial dysfunction., 10 (3):[PMID:30996858][10.1039/C8MD00582F]